Take a look at some of Monday's morning movers:
SanDisk - Goldman Sachs has upgraded the flash memory product maker to "buy" from "neutral," because of factors like an improved supply/demand balance.
Netflix - The stock has been upgraded to "neutral" from "sell" at Janney Capital. The firm believes the risk/reward ratio is more balanced after a recent selloff and downward revisions in earnings estimates by a number of Wall Street analysts.
Boeing - Oppenheimer has upgraded the jet maker's stock to "outperform" from "perform," saying investors are ignoring the growing momentum of the 787 Dreamliner aircraft.
Watson Pharmaceuticals - The U.S. Food and Drug Administration has approved its generic version of hyperactivity drug Adderall XR. Adderall’s maker, Britain’s Shire, had sought to block the generic version from coming to market.
Abbott Laboratories - Belgian drugmaker Ablynx said its arthritis treatment shows a benefit over Abbott’s best-selling Humira.
Research In Motion - RIM is considering
Toyota Motor - The automaker will reportedly extend its partnership with BMW by providing hybrid technology, according to the Nikkei business daily. The paper said the two companies will hold a news conference in Germany later this week.
Walt Disney - The Pixar movie “Brave” topped the weekend box office with $66.7 million in North American ticket sales, above analyst forecasts.
Yahoo - Yahoo is reportedly returning to a focus on online advertising, according to The Wall Street Journal. The paper says CEO Ross Levinsohn is pushing aside a recent emphasis on generating more e-commerce revenue.
Lockheed Martin - Machinists have reached a tentative labor contract with the defense contractor, a deal that would end a more than two month old strike. A vote on the pact is expected later this week.
Aetna, United Healthcare, Tenet Healthcare, MetLife, others - Health-care stocks may be in the spotlight this week, with the U.S. Supreme Court likely to rule on the constitutionality of President Barack Obama’s health-care reform law. That decision could come as soon as today.
Google - CEO Larry Page moves to reassure employees about his health. Page missed the annual shareholders meeting last week and will miss two other upcoming appearances because of unspecified problems that have caused him to lose his voice. Page tells employees there is “nothing seriously wrong.”
—By CNBC’s Peter Schacknow
Questions? Comments? Email us at firstname.lastname@example.org